Peter Llewellyn-Davies
Direktor/Vorstandsmitglied bei SHIELD THERAPEUTICS PLC
Vermögen: 3 006 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Peter Llewellyn-Davies
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
| Public Company | Pharmaceuticals: Major | 12 | |
12
| Public Company | Biotechnology | 12 |
11
| Public Company | Financial Conglomerates | 11 |
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria.
8
| Holding Company | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter Llewellyn-Davies
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| 4BASEBIO PLC | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
Expedeon Ltd.
 Expedeon Ltd. BiotechnologyHealth Technology Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
Phosphate Therapeutics Ltd.
 Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member General Counsel Director of Finance/CFO | |
Expedeon Holdings Ltd.
 Expedeon Holdings Ltd. BiotechnologyHealth Technology Expedeon Holdings Ltd. develops, manufactures, and commercializes proteomics reagents and tools. The company was founded on January 7, 2009 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder | |
| BIOFRONTERA AG | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director of Finance/CFO | |
| MORPHOSYS AG | Biotechnology | Director of Finance/CFO Director/Board Member Human Resources Officer | |
| OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
Heqet Therapeutics SRL
 Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree Corporate Officer/Principal | |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Chairman Private Equity Investor | |
| STADA ARZNEIMITTEL | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
4basebio UK Ltd.
 4basebio UK Ltd. Wholesale DistributorsDistribution Services 4basebio Ltd. engages in the genomics and DNA manufacturing business. The company was founded on November 5, 2019 and is headquartered in Cambridge, the United Kingdom. | Wholesale Distributors | Director/Board Member Director/Board Member | |
| Hoechst Marion Roussel, Inc. | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | ||
Genetrix SL
 Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Biotechnology | Founder Chief Executive Officer | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Corporate Officer/Principal | |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Technical University of Berlin | College/University | Undergraduate Degree Corporate Officer/Principal | |
Balaton Agro Invest AG
 Balaton Agro Invest AG Financial ConglomeratesFinance Balaton Agro Invest AG provides investment services. The private company is based in Heidelberg, Germany. and has subsidiaries in Ethiopia. Balaton Agro Invest was founded in 2011. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| MIT Sloan School of Management | College/University | Graduate Degree Graduate Degree | |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| MISTRAL MEDIA AG | Financial Conglomerates | Corporate Officer/Principal Director/Board Member | |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree Doctorate Degree | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| EPIGENOMICS AG | Medical Specialties | Director/Board Member Director/Board Member | |
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| 4SC AG | Biotechnology | Director/Board Member Chairman | |
| HEIDELBERGER BETEILIGUNGSHOLDING AG | Financial Conglomerates | Corporate Officer/Principal Chairman | |
| University of Zurich | College/University | Doctorate Degree Undergraduate Degree | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | President Sales & Marketing | |
| MING LE SPORTS AG | Apparel/Footwear | Corporate Officer/Principal Director/Board Member | |
Nordic SSW 1000 Verwaltungs AG
 Nordic SSW 1000 Verwaltungs AG Financial ConglomeratesFinance Nordic SSW 1000 Verwaltungs AG is an investment holding German company. The private company is based in Hamburg, Germany. | Financial Conglomerates | Chairman Director/Board Member | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| VECTURA GROUP | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Corporate Officer/Principal Director of Finance/CFO | |
Archimedes Pharma Ltd.
 Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel |
Statistik
International
| Deutschland | 26 |
| Vereinigtes Königreich | 14 |
| Vereinigte Staaten | 7 |
| Schweiz | 3 |
| Italien | 2 |
Sektoral
| Health Technology | 29 |
| Commercial Services | 7 |
| Consumer Services | 7 |
| Finance | 6 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 409 |
| Corporate Officer/Principal | 139 |
| Chairman | 112 |
| Chief Executive Officer | 88 |
| Independent Dir/Board Member | 60 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Hansjörg Plaggemars | 44 |
| Christof Hettich | 40 |
| Cristina Garmendia Mendizábal | 38 |
| Norbert Riedel | 29 |
| Helmut Schühsler | 28 |
| Hans-Peter Hasler | 28 |
| Rolf K. Hoffmann | 27 |
| David Ebsworth | 26 |
| Thomas Werner | 25 |
| David Lemus | 22 |
| Andrew Heath | 20 |
| Tim McCarthy McCarthy | 20 |
| James Karis | 20 |
| Karl Keegan | 18 |
| Heikki Lanckriet | 17 |
- Börse
- Insiders
- Peter Llewellyn-Davies
- Unternehmensverbindungen
